APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Based on Gene Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drug Based on Gene Therapy Industry Growth and Trends Forecast to 2032

2 January 2026102 pages

Choose your research edition.

Industry ResearchDrug Based on Gene Therapy Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Based on Gene Therapy Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Drug Based on Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Based on Gene Therapy Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Based on Gene Therapy Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Drug Based on Gene Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drug Based on Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drug Based on Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Based on Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Drug Based on Gene Therapy market include Novartis, Biogen, Amgen, Sunway Biotech, Spark Therapeutics, SIBIONO, Sarepta Therapeutics, Orchard Therapeutics and Human Stem Cells Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drug Based on Gene Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug Based on Gene Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Based on Gene Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Based on Gene Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drug Based on Gene Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug Based on Gene Therapy Market by Company

Novartis

Biogen

Amgen

Sunway Biotech

Spark Therapeutics

SIBIONO

Sarepta Therapeutics

Orchard Therapeutics

Human Stem Cells Institute

Gilead Sciences

bluebird bio

AnGes

Alnylam Pharmaceuticals

Akcea Therapeutics

Drug Based on Gene Therapy Segment by Type

Viral Gene Therapy

Non-viral Gene Therapy

Drug Based on Gene Therapy Segment by Application

Neurological Diseases

Cancer

Other

Drug Based on Gene Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Based on Gene Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Based on Gene Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Based on Gene Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drug Based on Gene Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drug Based on Gene Therapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drug Based on Gene Therapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drug Based on Gene Therapy Market Share by Region (2021-2026) Table 4. Global Drug Based on Gene Therapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drug Based on Gene Therapy Market Share by Region (2027-2032) Table 6. Global Drug Based on Gene Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drug Based on Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drug Based on Gene Therapy Market Size Share by Type (2021-2026) Table 9. Global Drug Based on Gene Therapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drug Based on Gene Therapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drug Based on Gene Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drug Based on Gene Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drug Based on Gene Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drug Based on Gene Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drug Based on Gene Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drug Based on Gene Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drug Based on Gene Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drug Based on Gene Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drug Based on Gene Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drug Based on Gene Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drug Based on Gene Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drug Based on Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drug Based on Gene Therapy Market Size Share by Application (2021-2026) Table 24. Global Drug Based on Gene Therapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drug Based on Gene Therapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drug Based on Gene Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drug Based on Gene Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drug Based on Gene Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drug Based on Gene Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drug Based on Gene Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drug Based on Gene Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drug Based on Gene Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drug Based on Gene Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drug Based on Gene Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drug Based on Gene Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drug Based on Gene Therapy Industry Trends Table 37. Drug Based on Gene Therapy Industry Drivers Table 38. Drug Based on Gene Therapy Industry Opportunities and Challenges Table 39. Drug Based on Gene Therapy Industry Restraints Table 40. Global Drug Based on Gene Therapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drug Based on Gene Therapy Revenue Market Share by Company (2021-2026) Table 42. Global Drug Based on Gene Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drug Based on Gene Therapy Key Company Headquarters & Area Served Table 44. Global Drug Based on Gene Therapy Company, Product Type & Application Table 45. Global Drug Based on Gene Therapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drug Based on Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis Company Information Table 49. Novartis Business Overview Table 50. Novartis Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis Drug Based on Gene Therapy Product Portfolio Table 52. Novartis Recent Development Table 53. Biogen Company Information Table 54. Biogen Business Overview Table 55. Biogen Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Biogen Drug Based on Gene Therapy Product Portfolio Table 57. Biogen Recent Development Table 58. Amgen Company Information Table 59. Amgen Business Overview Table 60. Amgen Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Amgen Drug Based on Gene Therapy Product Portfolio Table 62. Amgen Recent Development Table 63. Sunway Biotech Company Information Table 64. Sunway Biotech Business Overview Table 65. Sunway Biotech Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sunway Biotech Drug Based on Gene Therapy Product Portfolio Table 67. Sunway Biotech Recent Development Table 68. Spark Therapeutics Company Information Table 69. Spark Therapeutics Business Overview Table 70. Spark Therapeutics Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Spark Therapeutics Drug Based on Gene Therapy Product Portfolio Table 72. Spark Therapeutics Recent Development Table 73. SIBIONO Company Information Table 74. SIBIONO Business Overview Table 75. SIBIONO Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. SIBIONO Drug Based on Gene Therapy Product Portfolio Table 77. SIBIONO Recent Development Table 78. Sarepta Therapeutics Company Information Table 79. Sarepta Therapeutics Business Overview Table 80. Sarepta Therapeutics Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Sarepta Therapeutics Drug Based on Gene Therapy Product Portfolio Table 82. Sarepta Therapeutics Recent Development Table 83. Orchard Therapeutics Company Information Table 84. Orchard Therapeutics Business Overview Table 85. Orchard Therapeutics Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Orchard Therapeutics Drug Based on Gene Therapy Product Portfolio Table 87. Orchard Therapeutics Recent Development Table 88. Human Stem Cells Institute Company Information Table 89. Human Stem Cells Institute Business Overview Table 90. Human Stem Cells Institute Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Human Stem Cells Institute Drug Based on Gene Therapy Product Portfolio Table 92. Human Stem Cells Institute Recent Development Table 93. Gilead Sciences Company Information Table 94. Gilead Sciences Business Overview Table 95. Gilead Sciences Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Gilead Sciences Drug Based on Gene Therapy Product Portfolio Table 97. Gilead Sciences Recent Development Table 98. bluebird bio Company Information Table 99. bluebird bio Business Overview Table 100. bluebird bio Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. bluebird bio Drug Based on Gene Therapy Product Portfolio Table 102. bluebird bio Recent Development Table 103. AnGes Company Information Table 104. AnGes Business Overview Table 105. AnGes Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. AnGes Drug Based on Gene Therapy Product Portfolio Table 107. AnGes Recent Development Table 108. Alnylam Pharmaceuticals Company Information Table 109. Alnylam Pharmaceuticals Business Overview Table 110. Alnylam Pharmaceuticals Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Portfolio Table 112. Alnylam Pharmaceuticals Recent Development Table 113. Akcea Therapeutics Company Information Table 114. Akcea Therapeutics Business Overview Table 115. Akcea Therapeutics Drug Based on Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Akcea Therapeutics Drug Based on Gene Therapy Product Portfolio Table 117. Akcea Therapeutics Recent Development Table 118. North America Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Drug Based on Gene Therapy Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Drug Based on Gene Therapy Market Share by Country (2021-2026) Table 121. North America Drug Based on Gene Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Drug Based on Gene Therapy Market Share Forecast by Country (2027-2032) Table 123. Europe Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Drug Based on Gene Therapy Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Drug Based on Gene Therapy Market Share by Country (2021-2026) Table 126. Europe Drug Based on Gene Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Drug Based on Gene Therapy Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Drug Based on Gene Therapy Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Drug Based on Gene Therapy Market Share by Country (2021-2026) Table 131. Asia-Pacific Drug Based on Gene Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Drug Based on Gene Therapy Market Share Forecast by Country (2027-2032) Table 133. Latin America Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Drug Based on Gene Therapy Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Drug Based on Gene Therapy Market Share by Country (2021-2026) Table 136. Latin America Drug Based on Gene Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Drug Based on Gene Therapy Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Drug Based on Gene Therapy Market Share by Country (2021-2026) Table 141. Middle East & Africa Drug Based on Gene Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Drug Based on Gene Therapy Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drug Based on Gene Therapy Product Image Figure 3. Global Drug Based on Gene Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drug Based on Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 5. Global Drug Based on Gene Therapy Market Share by Region: 2025 VS 2032 Figure 6. Global Drug Based on Gene Therapy Market Share by Region (2021-2032) Figure 7. North America Drug Based on Gene Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drug Based on Gene Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drug Based on Gene Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drug Based on Gene Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drug Based on Gene Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Viral Gene Therapy Image Figure 13. Global Viral Gene Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-viral Gene Therapy Image Figure 15. Global Non-viral Gene Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Drug Based on Gene Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Drug Based on Gene Therapy Market Share by Type 2025 VS 2032 Figure 18. North America Drug Based on Gene Therapy Market Size Share by Type (2021-2032) Figure 19. Europe Drug Based on Gene Therapy Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Drug Based on Gene Therapy Market Size Share by Type (2021-2032) Figure 21. Latin America Drug Based on Gene Therapy Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Drug Based on Gene Therapy Market Size Share by Type (2021-2032) Figure 23. Neurological Diseases Image Figure 24. Global Neurological Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Cancer Image Figure 26. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Drug Based on Gene Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Drug Based on Gene Therapy Market Share by Application 2025 VS 2032 Figure 31. North America Drug Based on Gene Therapy Market Size Share by Application (2021-2032) Figure 32. Europe Drug Based on Gene Therapy Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Drug Based on Gene Therapy Market Size Share by Application (2021-2032) Figure 34. Latin America Drug Based on Gene Therapy Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Drug Based on Gene Therapy Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Drug Based on Gene Therapy Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Drug Based on Gene Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Drug Based on Gene Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Drug Based on Gene Therapy Market Share by Country (2021-2032) Figure 41. Europe Drug Based on Gene Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Drug Based on Gene Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Drug Based on Gene Therapy Market Share by Country (2021-2032) Figure 44. Asia-Pacific Drug Based on Gene Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Drug Based on Gene Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Drug Based on Gene Therapy Market Share by Country (2021-2032) Figure 47. Latin America Drug Based on Gene Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Drug Based on Gene Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Drug Based on Gene Therapy Market Share by Country (2021-2032) Figure 50. Middle East & Africa Drug Based on Gene Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Drug Based on Gene Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Drug Based on Gene Therapy Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Gene Therapy
  • Non-viral Gene Therapy
Applications
  • Neurological Diseases
  • Cancer
  • Other
Companies covered
  • Novartis
  • Biogen
  • Amgen
  • Sunway Biotech
  • Spark Therapeutics
  • SIBIONO
  • Sarepta Therapeutics
  • Orchard Therapeutics
  • Human Stem Cells Institute
  • Gilead Sciences
  • bluebird bio
  • AnGes
  • Alnylam Pharmaceuticals
  • Akcea Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drug Based on Gene Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drug Based on Gene Therapy Market Size by Region (2021-2032)
  5. 1.4.1 Global Drug Based on Gene Therapy Market Size by Region (2021-2026)
  6. 1.4.2 Global Drug Based on Gene Therapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drug Based on Gene Therapy Market Size (2021-2032)
  8. 1.5.1 North America Drug Based on Gene Therapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drug Based on Gene Therapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drug Based on Gene Therapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drug Based on Gene Therapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drug Based on Gene Therapy Market Size Growth Rate (2021-2032)
2 Drug Based on Gene Therapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Viral Gene Therapy
  3. 2.1.2 Non-viral Gene Therapy
  4. 2.2 Global Drug Based on Gene Therapy Market Size by Type
  5. 2.2.1 Global Drug Based on Gene Therapy Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Drug Based on Gene Therapy Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Drug Based on Gene Therapy Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Drug Based on Gene Therapy Market Size by Regions
  9. 2.3.1 North America Drug Based on Gene Therapy Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Drug Based on Gene Therapy Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Drug Based on Gene Therapy Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Drug Based on Gene Therapy Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Drug Based on Gene Therapy Market Size Breakdown by Type (2021-2026)
3 Drug Based on Gene Therapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Neurological Diseases
  3. 3.1.2 Cancer
  4. 3.1.3 Other
  5. 3.2 Global Drug Based on Gene Therapy Market Size by Application
  6. 3.2.1 Global Drug Based on Gene Therapy Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Drug Based on Gene Therapy Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Drug Based on Gene Therapy Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Drug Based on Gene Therapy Market Size by Regions
  10. 3.3.1 North America Drug Based on Gene Therapy Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Drug Based on Gene Therapy Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Drug Based on Gene Therapy Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Drug Based on Gene Therapy Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Drug Based on Gene Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drug Based on Gene Therapy Industry Trends
  2. 4.2 Drug Based on Gene Therapy Industry Drivers
  3. 4.3 Drug Based on Gene Therapy Industry Opportunities and Challenges
  4. 4.4 Drug Based on Gene Therapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drug Based on Gene Therapy Revenue (2021-2026)
  2. 5.2 Global Drug Based on Gene Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drug Based on Gene Therapy Key Company Headquarters & Area Served
  4. 5.4 Global Drug Based on Gene Therapy Company, Product Type & Application
  5. 5.5 Global Drug Based on Gene Therapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drug Based on Gene Therapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drug Based on Gene Therapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drug Based on Gene Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Drug Based on Gene Therapy Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Biogen
  8. 6.2.1 Biogen Company Information
  9. 6.2.2 Biogen Business Overview
  10. 6.2.3 Biogen Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Biogen Drug Based on Gene Therapy Product Portfolio
  12. 6.2.5 Biogen Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Drug Based on Gene Therapy Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Sunway Biotech
  20. 6.4.1 Sunway Biotech Company Information
  21. 6.4.2 Sunway Biotech Business Overview
  22. 6.4.3 Sunway Biotech Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sunway Biotech Drug Based on Gene Therapy Product Portfolio
  24. 6.4.5 Sunway Biotech Recent Developments
  25. 6.5 Spark Therapeutics
  26. 6.5.1 Spark Therapeutics Company Information
  27. 6.5.2 Spark Therapeutics Business Overview
  28. 6.5.3 Spark Therapeutics Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Spark Therapeutics Drug Based on Gene Therapy Product Portfolio
  30. 6.5.5 Spark Therapeutics Recent Developments
  31. 6.6 SIBIONO
  32. 6.6.1 SIBIONO Company Information
  33. 6.6.2 SIBIONO Business Overview
  34. 6.6.3 SIBIONO Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 SIBIONO Drug Based on Gene Therapy Product Portfolio
  36. 6.6.5 SIBIONO Recent Developments
  37. 6.7 Sarepta Therapeutics
  38. 6.7.1 Sarepta Therapeutics Company Information
  39. 6.7.2 Sarepta Therapeutics Business Overview
  40. 6.7.3 Sarepta Therapeutics Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Sarepta Therapeutics Drug Based on Gene Therapy Product Portfolio
  42. 6.7.5 Sarepta Therapeutics Recent Developments
  43. 6.8 Orchard Therapeutics
  44. 6.8.1 Orchard Therapeutics Company Information
  45. 6.8.2 Orchard Therapeutics Business Overview
  46. 6.8.3 Orchard Therapeutics Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Orchard Therapeutics Drug Based on Gene Therapy Product Portfolio
  48. 6.8.5 Orchard Therapeutics Recent Developments
  49. 6.9 Human Stem Cells Institute
  50. 6.9.1 Human Stem Cells Institute Company Information
  51. 6.9.2 Human Stem Cells Institute Business Overview
  52. 6.9.3 Human Stem Cells Institute Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Human Stem Cells Institute Drug Based on Gene Therapy Product Portfolio
  54. 6.9.5 Human Stem Cells Institute Recent Developments
  55. 6.10 Gilead Sciences
  56. 6.10.1 Gilead Sciences Company Information
  57. 6.10.2 Gilead Sciences Business Overview
  58. 6.10.3 Gilead Sciences Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Gilead Sciences Drug Based on Gene Therapy Product Portfolio
  60. 6.10.5 Gilead Sciences Recent Developments
  61. 6.11 bluebird bio
  62. 6.11.1 bluebird bio Company Information
  63. 6.11.2 bluebird bio Business Overview
  64. 6.11.3 bluebird bio Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 bluebird bio Drug Based on Gene Therapy Product Portfolio
  66. 6.11.5 bluebird bio Recent Developments
  67. 6.12 AnGes
  68. 6.12.1 AnGes Company Information
  69. 6.12.2 AnGes Business Overview
  70. 6.12.3 AnGes Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 AnGes Drug Based on Gene Therapy Product Portfolio
  72. 6.12.5 AnGes Recent Developments
  73. 6.13 Alnylam Pharmaceuticals
  74. 6.13.1 Alnylam Pharmaceuticals Company Information
  75. 6.13.2 Alnylam Pharmaceuticals Business Overview
  76. 6.13.3 Alnylam Pharmaceuticals Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Portfolio
  78. 6.13.5 Alnylam Pharmaceuticals Recent Developments
  79. 6.14 Akcea Therapeutics
  80. 6.14.1 Akcea Therapeutics Company Information
  81. 6.14.2 Akcea Therapeutics Business Overview
  82. 6.14.3 Akcea Therapeutics Drug Based on Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Akcea Therapeutics Drug Based on Gene Therapy Product Portfolio
  84. 6.14.5 Akcea Therapeutics Recent Developments
7 North America
  1. 7.1 North America Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drug Based on Gene Therapy Market Size by Country (2021-2026)
  3. 7.3 North America Drug Based on Gene Therapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drug Based on Gene Therapy Market Size by Country (2021-2026)
  3. 8.3 Europe Drug Based on Gene Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drug Based on Gene Therapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drug Based on Gene Therapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drug Based on Gene Therapy Market Size by Country (2021-2026)
  3. 10.3 South America Drug Based on Gene Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drug Based on Gene Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drug Based on Gene Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst